Day: April 8, 2020

Onsdag den 29. april 2020, kl. 10.00i Tivoli Congress CenterArni Magnussons Gade 2-4, 2. sal1577 København VDagsorden

WELLINGTON, Fla., April 08, 2020 (GLOBE NEWSWIRE) — KLX Energy Services Holdings, Inc. (“KLX Energy Services” or the “Company”) (NASDAQ: KLXE) announced today several additional cost reduction measures being taken in response to rapidly deteriorating market conditions as a result of the unprecedented demand destruction being caused by the Covid-19 pandemic in addition to the Saudi Arabia/Russia oil market share price war.On March 9, 2020, the Company announced that it had initiated a cost rationalization program in which it implemented an approximately 360 person, or 22%, reduction in force. The Company is announcing today an additional reduction in its workforce of approximately 170 employees, which it expects to complete by April 10, 2020.  In addition, the Company has instituted a widespread wage reduction program. The aggregate...

UAB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 600 000 000 EUR; ISIN codes XS1646530565; XS1853999313. The Company hereby notifies that on the 8th of April 2020 amendment of  the Articles of Association, which establishes that Supervisory Board of the Company is composed not from 5, but from 7 members (2 representatives of shareholder and 5 independent members), were registered in the Register of Legal Entities and entered into force. The Articles of Association of the Company were amended by the decision of the Ministry of Finance of the Republic of Lithuania, which is the body implementing the rights of the shareholder of the Company, on the 26th of March 2020.  More information the Company...

UAB „Ignitis grupė“ (toliau – Bendrovė),  juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra UAB „Ignitis grupė“ išleistų obligacijų nominali vertė 600000000 EUR; ISIN kodai: XS1646530565; XS1853999313. Bendrovė informuoja, kad 2020 m. balandžio 8 d. Juridinių asmenų registre įregistruoti ir įsigaliojo naujos redakcijos Bendrovės įstatai, kuriuose numatyta, kad Bendrovės stebėtojų tarybą sudaro nebe 5, o 7 nariai (2 akcininko atstovai ir 5 nepriklausomi nariai). Bendrovės įstatai buvo pakeisti 2020 m. kovo 26 d. Bendrovės akcininko teises įgyvendinančios  Lietuvos Respublikos finansų ministerijos sprendimu.  Plačiau apie tai Bendrovė pranešė 2020 m. kovo 27 d. pranešimu apie esminį įvykį (nuoroda).  Artimiausiu metu Finansų ministerija planuoja inicijuoti atranką į dviejų nepriklausomų Bendrovės...

SUNNYVALE, Calif., April 08, 2020 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary first quarter 2020 operational results. Full financial results for the Company’s first quarter of 2020 will be provided on the Company’s earnings call scheduled for April 16, 2020.First quarter 2020 estimated worldwide da Vinci procedures increased approximately 10% compared with the first quarter of 2019. The Company shipped 237 da Vinci Surgical Systems in the first quarter of 2020 compared with 235 in the first quarter of 2019. As previously disclosed in an 8-K filed on March 16, 2020, the Company experienced disruption of procedures in countries with healthcare systems impacted early by the...

Dr. Chow to work with Draganfly to implement the Vital Intelligence camera and drone technology in the United States to combat COVID-19 (Coronavirus)Vancouver, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and unmanned vehicle sector (“UVS”), today announced that its Board of Directors has appointed Dr. Jack C. Chow as an advisory member to its Board.Draganfly announced on March 26, 2020 that it had been selected as the exclusive global systems integrator for the Vital Intelligence Project a healthcare data services & deep learning company in conjunction with the University of South Australia,...

EDEN PRAIRIE, Minn., April 08, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, clinician-led webinar to discuss cardio-pulmonary-renal management in real-world COVID-19 patients. Dr. Daniel J. Goldstein, Professor & Vice Chairman, Department of Cardiothoracic Surgery, Montefiore Medical Center, New York will moderate the online discussion on Friday, April 10 at 1:00 p.m. EDT.Clinicians will present COVID-19 Case Studies in a grand rounds format and discuss:Complex fluid balance and fluid overload managementStrategies for managing cardio-pulmonary status and hemodynamic stateManaging the continuum of acute kidney injury (AKI) through end-stage renal disease (ESRD)Current...

Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) — Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collaboration with Premas Biotech has successfully completed a second milestone, the successful expression of the three coronavirus antigens, Spike (S), Envelope (E), and Membrane (M), that were selected for their vaccine candidate. The antigens have been expressed using the D-CryptTM platform at Premas Biotech, which utilizes its vectors and S cerevisiae strain. Premas is now moving forward with purification and post-expression processing, which we believe should lead to a scaling up of the antigens.Prabuddha Kundu, Co-Founder and Managing Director at Premas Biotech, commented, “We are happy to announce our success in expressing all three...

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, is pleased to announce that the Company has retained Novotech, the largest biotech clinical research organization (“CRO”) specialist in the Asia-Pacific region, to serve as the Company’s CRO to pursue future human clinical studies for Bucillamine in the treatment of infectious diseases, including the coronavirus disease (“COVID-19”) in Asia-Pacific Countries (“APAC”).“We are pleased to have Novotech as part of our team to support us in our global clinical strategy for Bucillamine in infectious diseases, which includes COVID-19, and they will work in parallel and complement our initiatives in the U.S.,...

Creates CISO Council and Advisory Board Names Alex Stamos As Advisor CEO Eric Yuan to Host First Weekly Webinar Wednesday, April 8SAN JOSE, Calif., April 08, 2020 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today published a blog post by founder and CEO Eric Yuan with an update on its 90-day plan to better identify, address, and fix issues proactively and improve the safety, privacy, and security of Zoom’s platform. This update includes the creation of a CISO Council and Advisory Board and the hiring of Alex Stamos, former Chief Security Officer of Facebook, as an outside advisor.The Company will also be hosting its first weekly webinar led by Eric Yuan on April 8, 2020 at 10am PT to provide privacy and security updates to its community and address community questions live.The full text of the blog post is as...